Chiusura precedente | 217,22 |
Aperto | 216,15 |
Denaro | 0,00 x 1200 |
Lettera | 0,00 x 800 |
Min-Max giorno | 215,29 - 219,87 |
Intervallo di 52 settimane | 201,65 - 283,09 |
Volume | |
Media Volume | 514.027 |
Capitalizzazione | 10,256B |
Beta (5 anni mensile) | 0,60 |
Rapporto PE (ttm) | 14,25 |
EPS (ttm) | 15,36 |
Prossima data utili | 01 ago 2023 - 07 ago 2023 |
Rendimento e dividendo (forward) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 281,18 |
h-VIOS2 h-VIOS2 containing two perfused vascularized hydrogels. Within this chip’s footprint, any vasculature can be created. Taci Pereira Taci Pereira named CEO of Systemic Bio. New company will leverage 3D Systems’ recent breakthroughs in bioprinting of vascularized human organs and tissues to accelerate new drug development, reduce costs, and ultimately reduce or eliminate the need for animal testingUnique bioprinted organ-on-a-chip platform, h-VIOS™, created using hydrogels to produce comple
United Therapeutics Corporation (UTHR) stock has jumped this year, gaining 10% so far.